With increasing pressure to reduce healthcare costs globally, emerging markets particularly India is gaining further prominence with its scientific and tech talent pool, contract research and manufacturing activities, process reengineering and innovative R&D capabilities serving as key enablers. Under this backdrop, 13th BioAsia will focus on connecting the dots to build stakeholder consensus and draw distinct roadmap.

Seen widely as a catalyst for the life sciences industry, providing a platform for B2B meetings, advocating policies and discussing the roadmap for the Industry, the event has emerged as the biggest event in the country in every perspective, in terms of footfalls, B2B meetings, business transactions, working group discussions, participation of global thought leaders etc.

More information: http://www.2016.bioasia.in/theme.html